M&A · Healthcare · Buyer's industry: Medicinal Chemicals & Botanical Products
Niagen Bioscience, Inc. to acquire Core Nicotinamide Riboside
Announced Dec 22, 2025 · Closed Dec 22, 2025 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed
Transaction
- Acquirer
- Niagen Bioscience, Inc. (NAGE)
- Target
- Core Nicotinamide Riboside
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Dec 22, 2025
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Medicinal Chemicals & Botanical Products